OBJECTIVE: To characterize the graft survivorship and clinical outcomes of osteochondral allograft transplantation (OCA) of the knee in patients with an elevated body mass index (BMI). DESIGN: Prospective data on 38 consecutive patients with a BMI ≥30 kg/m2 treated with OCA from 2000 to 2015 were reviewed. Complications, reoperations, and patient responses to validated outcome measures were examined. Failures were defined by any removal/revision of the allograft or conversion to arthroplasty. RESULTS: Thirty-one knees in 31 patients (mean age, 35.4 years [range, 17-61 years]; 87% male) met the inclusion criteria. Mean BMI was 32.9 kg/m2 (range, 30-39 kg/m2). Mean chondral defect size was 6.4 cm2 (range, 1.0-15.3 cm2). Prior to OCA, 23 patients (74%) had undergone previous surgery to the ipsilateral knee. Mean duration of follow-up was 4.1 years (range, 2-11 years). After OCA, 5 knees (13%) underwent conversion to unicompartmental (1) or total (4) knee arthroplasty. Two- and 5-year graft survivorship were 87% and 83%, respectively. At final follow-up, clinically significant improvements were noted in the pain (49.3-72.6) and physical functioning (52.9-81.3) subscales of the Short Form-36 ( P ≤ 0.001), International Knee Documentation Committee subjective form (43.5-67.0; P = 0.002), Knee Outcome Survey-Activities of Daily Living (58.2-80.4; P = 0.002), and overall condition subscale of the Cincinnati Knee Rating System (4.7-6.9; P = 0.046). CONCLUSIONS: OCA can be a successful midterm treatment option for focal cartilage defects of the knee in select patients with a BMI ≥30 kg/m2.
OBJECTIVE: To characterize the graft survivorship and clinical outcomes of osteochondral allograft transplantation (OCA) of the knee in patients with an elevated body mass index (BMI). DESIGN: Prospective data on 38 consecutive patients with a BMI ≥30 kg/m2 treated with OCA from 2000 to 2015 were reviewed. Complications, reoperations, and patient responses to validated outcome measures were examined. Failures were defined by any removal/revision of the allograft or conversion to arthroplasty. RESULTS: Thirty-one knees in 31 patients (mean age, 35.4 years [range, 17-61 years]; 87% male) met the inclusion criteria. Mean BMI was 32.9 kg/m2 (range, 30-39 kg/m2). Mean chondral defect size was 6.4 cm2 (range, 1.0-15.3 cm2). Prior to OCA, 23 patients (74%) had undergone previous surgery to the ipsilateral knee. Mean duration of follow-up was 4.1 years (range, 2-11 years). After OCA, 5 knees (13%) underwent conversion to unicompartmental (1) or total (4) knee arthroplasty. Two- and 5-year graft survivorship were 87% and 83%, respectively. At final follow-up, clinically significant improvements were noted in the pain (49.3-72.6) and physical functioning (52.9-81.3) subscales of the Short Form-36 ( P ≤ 0.001), International Knee Documentation Committee subjective form (43.5-67.0; P = 0.002), Knee Outcome Survey-Activities of Daily Living (58.2-80.4; P = 0.002), and overall condition subscale of the Cincinnati Knee Rating System (4.7-6.9; P = 0.046). CONCLUSIONS:OCA can be a successful midterm treatment option for focal cartilage defects of the knee in select patients with a BMI ≥30 kg/m2.
Entities:
Keywords:
BMI; body mass index; cartilage; obesity; osteochondral allograft
Authors: Thomas R Niethammer; Elem Safi; Andreas Ficklscherer; Annie Horng; Markus Feist; Isa Feist-Pagenstert; Volkmar Jansson; Matthias F Pietschmann; Peter E Müller Journal: Am J Sports Med Date: 2014-07-03 Impact factor: 6.202
Authors: A Escobar; J M Quintana; A Bilbao; I Aróstegui; I Lafuente; I Vidaurreta Journal: Osteoarthritis Cartilage Date: 2006-10-17 Impact factor: 6.576
Authors: Kai Mithoefer; Riley J Williams; Russell F Warren; Hollis G Potter; Christopher R Spock; Edward C Jones; Thomas L Wickiewicz; Robert G Marx Journal: J Bone Joint Surg Am Date: 2006-09 Impact factor: 5.284
Authors: Keith R Berend; Adolph V Lombardi; Thomas H Mallory; Joanne B Adams; Kari L Groseth Journal: Clin Orthop Relat Res Date: 2005-11 Impact factor: 4.176
Authors: Guilherme C Gracitelli; Gokhan Meric; Pamela A Pulido; Julie C McCauley; William D Bugbee Journal: Cartilage Date: 2015-04 Impact factor: 4.634
Authors: Kyle R Sochacki; Kunal Varshneya; Jacob G Calcei; Marc R Safran; Geoffrey D Abrams; Joseph Donahue; Constance Chu; Seth L Sherman Journal: Cartilage Date: 2020-10-27 Impact factor: 3.117
Authors: John R Matthews; Joseph M Brutico; Daniel T Abraham; Jeremy C Heard; Bradford S Tucker; Fotios P Tjoumakaris; Kevin B Freedman Journal: Orthop J Sports Med Date: 2022-02-09
Authors: Nicholas A Bonazza; Dallas M Smuin; Rajat Joshi; Djibril Ba; Guodong Liu; Douglas L Leslie; Aman Dhawan Journal: Arthrosc Sports Med Rehabil Date: 2019-11-29